GlassScriptPhysician profile
Absalom D Hepner
NPI 1205880994
$8,678.67
in general payments reported to CMS, 2019-2025
24 companies · $816 in 2025
The $816 reported for 2025 was more than what a typical Nuclear Cardiology provider received nationally (typical 2025 total: $434).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $516 · 2020: $101 · 2021: $169 · 2022: $656 · 2023: $492 · 2024: $5,929 · 2025: $816.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,160 · Food and Beverage: $2,069 · Travel and Lodging: $7.55.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,160.00 |
| Food and Beverage | $2,069.01 |
| Travel and Lodging | $7.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $5,479.68 | 2023-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Novartis Pharmaceuticals Corporation | $445.21 | 2019-2025 | |
| Boston Scientific Corporation | $427.85 | 2022-2025 | Rotapro, Avvigo Guidance System, Watchman Flx |
| Pfizer INC. | $392.92 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $377.99 | 2019-2025 | Camzyos, Eliquis |
| Merck Sharp & Dohme LLC | $310.39 | 2022-2025 | Verquvo |
| Sanofi-Aventis U.S. LLC | $261.35 | 2019-2023 | |
| Amgen INC. | $261.35 | 2019-2025 | Repatha |
| Irhythm Technologies, INC. | $110.59 | 2024 | Zio Monitor, Zio Xt Patch |
| Heartflow, INC. | $106.58 | 2023-2025 | Ffrct |
| Alnylam Pharmaceuticals INC. | $87.03 | 2025 | Amvuttra |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $49.17 | 2019-2025 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $46.69 | 2022-2023 | Jardiance |
| Abbott Laboratories | $41.54 | 2020-2022 | |
| Amarin Pharma, INC. | $40.77 | 2020-2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $40.21 | 2022-2023 | Nexletol |
| Janssen Pharmaceuticals, INC | $36.19 | 2019 | |
| Celgene Corporation | $33.51 | 2023 | Camzyos |
| Kowa Pharmaceuticals America, INC. | $24.50 | 2022 | |
| Corcept Therapeutics | $24.23 | 2025 | Korlym |
| Novo Nordisk INC | $23.62 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $22.89 | 2025 | |
| Impulse Dynamics (USA) INC. | $17.39 | 2022 | |
| Medtronic, INC. | $17.02 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Absalom Hepner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.